相关实验视频

Updated: Jul 22, 2026

A Screening Method for Identification of Heterochromatin-Promoting Drugs Using Drosophila
06:22

A Screening Method for Identification of Heterochromatin-Promoting Drugs Using Drosophila

Published on: March 12, 2020

5.9K

使用果模型从草药中发现用于治疗石病的活性化合物的简化策略

Yunuo Ren1, Wen Zhang1, Youxin Li1

  • 1School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, China.

Journal of ethnopharmacology
|April 25, 2025
PubMed
概括

这项研究开发了一种果模型,以快速识别用于治疗结石的传统中医药 (TCM) 的活性化合物. 在小鼠中发现并验证了三种化合物,显示出新疗法的潜力.

关键词:
活性化合物 有效化合物丹麦的丹麦人就是这样.这种植物是Drosophila melanogaster.红华 红华是什么意思黄奇奇是什么意思 黄奇奇是什么意思脏石病是一种神经质病.

更多相关视频

Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries08:20

Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries

Published on: March 31, 2021

6.2K
Author Spotlight: Advancing Antidiarrheal Research with the Drosophila Model07:38

Author Spotlight: Advancing Antidiarrheal Research with the Drosophila Model

Published on: November 17, 2023

1.3K

相关概念视频

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...